To confirm the role of PI3K/AKT signaling in aplysin-mediated breast cancer suppression, breast cancer cells were treated with 100 ng/mL IGF-1, an activator of PI3K/AKT signaling. The gene discussed is IGF1; the disease is breast cancer.